DE69710333T2 - Cyclopentan(en)säure-2-alkenyl-derivate als therapeutika in der behandlung der okulären hypertonie - Google Patents

Cyclopentan(en)säure-2-alkenyl-derivate als therapeutika in der behandlung der okulären hypertonie

Info

Publication number
DE69710333T2
DE69710333T2 DE69710333T DE69710333T DE69710333T2 DE 69710333 T2 DE69710333 T2 DE 69710333T2 DE 69710333 T DE69710333 T DE 69710333T DE 69710333 T DE69710333 T DE 69710333T DE 69710333 T2 DE69710333 T2 DE 69710333T2
Authority
DE
Germany
Prior art keywords
cyclopentan
therapeutic
acid
treatment
ocular hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69710333T
Other languages
English (en)
Other versions
DE69710333D1 (de
Inventor
E Garst
B Roof
F Chan
F Woodward
M Burk
S Gac
W Andrews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Sales LLC
Original Assignee
Allergan Sales LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Sales LLC filed Critical Allergan Sales LLC
Application granted granted Critical
Publication of DE69710333D1 publication Critical patent/DE69710333D1/de
Publication of DE69710333T2 publication Critical patent/DE69710333T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69710333T 1996-05-28 1997-05-14 Cyclopentan(en)säure-2-alkenyl-derivate als therapeutika in der behandlung der okulären hypertonie Expired - Fee Related DE69710333T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1843596P 1996-05-28 1996-05-28
PCT/US1997/008123 WO1997045405A1 (en) 1996-05-28 1997-05-14 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension

Publications (2)

Publication Number Publication Date
DE69710333D1 DE69710333D1 (de) 2002-03-21
DE69710333T2 true DE69710333T2 (de) 2002-09-19

Family

ID=21787915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69710333T Expired - Fee Related DE69710333T2 (de) 1996-05-28 1997-05-14 Cyclopentan(en)säure-2-alkenyl-derivate als therapeutika in der behandlung der okulären hypertonie

Country Status (8)

Country Link
US (1) US6258844B1 (de)
EP (1) EP0912507B1 (de)
JP (1) JP2000511530A (de)
AU (1) AU729318B2 (de)
CA (1) CA2256404A1 (de)
DE (1) DE69710333T2 (de)
ES (1) ES2170956T3 (de)
WO (1) WO1997045405A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0126075D0 (en) * 2001-10-31 2001-12-19 Cascade Biochem Ltd Improvements relating to prostaglandins and their analogues
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
MX361709B (es) 2009-11-09 2018-12-07 Allergan Inc Composiciones y metodos para estimular el crecimiento del cabello.
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
CN102757459B (zh) * 2011-04-29 2016-01-27 上海源力生物技术有限公司 用于合成前列腺素类药物的中间体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
CA2020254A1 (en) 1989-07-27 1991-01-28 Ming F. Chan Intraocular pressure reducing 9, 15-diacyl prostaglandins
US4994274A (en) 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
CA2021316C (en) 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives

Also Published As

Publication number Publication date
ES2170956T3 (es) 2002-08-16
AU729318B2 (en) 2001-02-01
EP0912507A1 (de) 1999-05-06
CA2256404A1 (en) 1997-12-04
DE69710333D1 (de) 2002-03-21
WO1997045405A1 (en) 1997-12-04
AU3066297A (en) 1998-01-05
EP0912507B1 (de) 2002-02-06
US6258844B1 (en) 2001-07-10
JP2000511530A (ja) 2000-09-05

Similar Documents

Publication Publication Date Title
EE04190B1 (et) Asendatud bensopüraani derivaatide kasutamine põletiku raviks
NO992806L (no) Terapeutiske midler
DE69736228D1 (de) Medizinische stents
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
NL1004716A1 (nl) Beenbeugel.
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
DE69817446D1 (de) Behandlung von diabetes
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
DE69524138T2 (de) Hautbehandlungsmittel
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
FI972919A (fi) Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa
DE69710333D1 (de) Cyclopentan(en)säure-2-alkenyl-derivate als therapeutika in der behandlung der okulären hypertonie
NO995723L (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
NO995722L (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
DE69739850D1 (de) Anti-reflektierende Behandlung von reflektierenden Oberflächen
DE69711779T2 (de) Neue Melatonin-Derivaten als Wirkstoff gegen freien Radikale sowie diese enthaltende Präparate
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
DE69722896D1 (de) Grossenverstellbare Sprunggelenkstütze
FR2697998B1 (fr) Chevillère.
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
FR2720270B1 (fr) Genouillère médicale.
NO970127D0 (no) Topiske sammensetninger for behandling av hudsykdom
KR970063938U (ko) 브이시알의 일체형 메인프레임

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee